S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack

Akari Therapeutics (AKTX) Short Interest Ratio & Short Volume

$2.28
-0.07 (-2.98%)
(As of 03/1/2024 ET)

Akari Therapeutics Short Interest Data

Current Short Volume
8,700 shares
Previous Short Volume
1,900 shares
Change Vs. Previous Month
+357.89%
Dollar Volume Sold Short
$20,706.00
Short Interest Ratio / Days to Cover
1.0
Last Record Date
February 15, 2024
Outstanding Shares
5,653,000 shares
Float Size
5,040,000 shares
Short Percent of Float
0.17%
Today's Trading Volume
9,264 shares
Average Trading Volume
4,905 shares
Today's Volume Vs. Average
189%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Akari Therapeutics ?

Sign up to receive the latest short interest report for Akari Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AKTX Short Interest Over Time

AKTX Days to Cover Over Time

AKTX Percentage of Float Shorted Over Time


Akari Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/20248,700 shares $20,706.00 +357.9%0.2%1 $2.38
1/31/20241,900 shares $4,807.00 -66.7%0.0%0.2 $2.53
1/15/20245,700 shares $16,416.00 +375.0%0.1%0.5 $2.88
12/31/20231,200 shares $3,744.00 -29.4%0.0%0.1 $3.12
12/15/20231,700 shares $4,760.00 -50.0%0.0%0.1 $2.80
11/30/20233,400 shares $10,030.00 -69.6%0.1%0.3 $2.95
11/15/202311,200 shares $35,504.00 -36.0%0.2%0.7 $3.17
10/31/202317,500 shares $61,425.00 +49.6%0.4%0.8 $3.51
10/15/202311,700 shares $42,705.00 -33.5%0.2%0.4 $3.65
9/30/202317,600 shares $69,520.00 +2.9%0.4%0.7 $3.95
9/15/202317,100 shares $62,244.00 +116.5%0.5%0.6 $3.64
8/31/20237,900 shares $24,885.00 -24.8%0.2%0.3 $3.15
8/15/202310,500 shares $39,585.00 -95.7%0.3%0.3 $3.77
7/31/2023243,800 shares $60,852.48 -29.2%N/A0.5 $0.25
7/15/2023344,200 shares $58,961.46 +67.3%N/A0.6 $0.17
6/30/2023205,700 shares $34,948.43 -1.5%N/A0.4 $0.17
6/15/2023208,800 shares $32,760.72 -3.7%N/A0.4 $0.16
5/31/2023216,700 shares $38,334.23 -5.2%N/A0.4 $0.18
5/15/2023228,600 shares $42,153.84 +104.5%N/A0.5 $0.18
4/30/2023111,800 shares $20,246.98 -62.3%N/A0.3 $0.18
4/15/2023296,900 shares $59,409.69 +128.0%N/A0.8 $0.20
3/31/2023130,200 shares $23,657.34 -21.5%N/A0.5 $0.18
3/15/2023165,800 shares $42,776.40 +79.4%N/A1.3 $0.26
2/28/202392,400 shares $31,878.00 +42.2%N/A0.8 $0.35
2/15/202365,000 shares $29,250.00 -30.6%N/A0.7 $0.45
1/31/202393,700 shares $43,739.16 -15.9%N/A1.2 $0.47
1/15/2023111,400 shares $60,111.44 +47.2%N/A1.4 $0.54
12/30/202275,700 shares $35,571.43 -2.1%N/A0.9 $0.47
12/15/202277,300 shares $35,558.00 -43.0%N/A1 $0.46
11/30/2022135,500 shares $74,877.30 -8.2%N/A1.3 $0.55
11/15/2022147,600 shares $84,279.60 +313.5%N/A1.5 $0.57
10/31/202235,700 shares $16,629.06 -44.8%N/A0.4 $0.47
10/15/202264,700 shares $31,470.08 -16.8%N/A0.7 $0.49
9/30/202277,800 shares $49,014.00 +215.0%0.5%0.8 $0.63
9/15/202224,700 shares $16,796.00 -10.5%0.2%0.3 $0.68
8/31/202227,600 shares $32,844.00 -47.1%0.2%0.4 $1.19
8/15/202252,200 shares $78,300.00 +1,435.3%0.4%0.7 $1.50
7/31/20223,400 shares $3,876.00 -95.0%0.0%0 $1.14
7/15/202267,300 shares $56,585.84 -10.7%0.5%1.1 $0.84
6/30/202275,400 shares $75,400.00 -30.1%0.5%1.4 $1.00













AKTX Short Interest - Frequently Asked Questions

What is Akari Therapeutics' current short interest?

Short interest is the volume of Akari Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 15th, investors have sold 8,700 shares of AKTX short. 0.17% of Akari Therapeutics' shares are currently sold short. Learn More on Akari Therapeutics' current short interest.

What is a good short interest ratio for Akari Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKTX shares currently have a short interest ratio of 1.0. Learn More on Akari Therapeutics's short interest ratio.

What is a good short interest percentage for Akari Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.17% of Akari Therapeutics' floating shares are currently sold short.

Is Akari Therapeutics' short interest increasing or decreasing?

Akari Therapeutics saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 8,700 shares, an increase of 357.9% from the previous total of 1,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Akari Therapeutics' float size?

Akari Therapeutics currently has issued a total of 5,650,000 shares. Some of Akari Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Akari Therapeutics currently has a public float of 5,040,000 shares.

How does Akari Therapeutics' short interest compare to its competitors?

0.17% of Akari Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Akari Therapeutics: VBI Vaccines Inc. (1.67%), TFF Pharmaceuticals, Inc. (0.86%), Galera Therapeutics, Inc. (8.58%), Mustang Bio, Inc. (0.58%), RenovoRx, Inc. (0.15%), Elevai Labs, Inc. (0.85%), AcelRx Pharmaceuticals, Inc. (3.16%), Benitec Biopharma Inc. (0.27%), Cocrystal Pharma, Inc. (0.04%), Purple Biotech Ltd. (1.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Akari Therapeutics stock?

Short selling AKTX is an investing strategy that aims to generate trading profit from Akari Therapeutics as its price is falling. AKTX shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Akari Therapeutics?

A short squeeze for Akari Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AKTX, which in turn drives the price of the stock up even further.

How often is Akari Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKTX, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:AKTX) was last updated on 3/2/2024 by MarketBeat.com Staff